Autopsy report · NCT00375141

Long-Pulsed Dye Laser and Intense Pulsed Light for Skin Rejuvenation.

“Inclusion, treatments and follow-up are finished”

The sponsor’s own words in the registry.

Life of this trial

• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Bispebjerg Hospital

Sponsor type

University, hospital or other

Conditions

Photodamaged Skin

Interventions

Pulsed dye laser, Intense pulsed light

Sites

1

Countries

Denmark

Trials that died the same way

• Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE)
  “The rate of inclusion is too low to hope to reach the target of 800 patients. 59 patients were included, and their data will not meet the research objectives. The sponsor has decided to prematurely stop inclusions on January 13, 2022.” (65% match in meaning)
• EXOme Rare Cancers in Children (EXOCARE)
  “Inclusions stopped due to lack of inclusions” (62% match in meaning)
• Bioavailability of Voriconazole
  “no eligible patients; study stopped without inclusion” (62% match in meaning)
• Exercise for Improving Prostate Oxygenation in Prostate Tumors (Exipox)
  “Slow inclusion rate due to patients operated before intervention is implementable” (61% match in meaning)
• Cetrotide Treatment Optimization
  “Due to limited rate of patient inclusion” (59% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.